MoneyWorks4Me

Neuland Laboratories informs about investor meetings

05 Jun 2026 Evaluate
Neuland Laboratories has informed that the Company’s management will be participating in the group analyst/ investor meeting(s) ‘Goldman Sachs Non-deal roadshow (NDR)’ on June 11, 2026 in Hyderabad (Group meet / One-on-One meet).

The above information is a part of company’s filings submitted to BSE.  

Neuland Laboratories Share Price

23222.15 716.55 (3.18%)
13-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1942.85
Dr. Reddys Labs. 1206.00
Cipla 1461.00
Lupin 2261.00
Zydus Lifesciences 1173.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: